Paul Hahn, MD: A Cross-Trial Comparison of Pegcetacoplan and Avacincaptad Pegol
July 31st 2023Dr. Hahn discusses an anchored matching-adjusted indirect comparison in patients with geographic atrophy, suggesting a greater reduction in observed lesion growth with monthly pegcetacoplan versus avacincaptad pegol.